Lack of toxicity of a STAT3 decoy oligonucleotide. - Wikidata - awgldk - TriplyDB

Lack of toxicity of a STAT3 decoy oligonucleotide.

Lack of toxicity of a STAT3 decoy oligonucleotide.

http://www.wikidata.org/entity/Q36175325

about

Nucleic acid-based approaches to STAT inhibition STAT3 inhibitors for cancer therapy: Have all roads been explored?STAT3 oligonucleotide inhibits tumor angiogenesis in preclinical models of squamous cell carcinoma STATs in cancer inflammation and immunity: a leading role for STAT3 High-content pSTAT3/1 imaging assays to screen for selective inhibitors of STAT3 pathway activation in head and neck cancer cell lines.STAT inhibitors for cancer therapy.Therapeutic modulators of STAT signalling for human diseases A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB.STAT3 signaling: anticancer strategies and challenges.The molecular pathogenesis of head and neck cancer.Targeting the interleukin-6/Jak/stat pathway in human malignancies First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy.Critical analysis of the potential for targeting STAT3 in human malignancy.Current and potential inflammation targeted therapies in head and neck cancer.Systemic administration of a cyclic signal transducer and activator of transcription 3 (STAT3) decoy oligonucleotide inhibits tumor growth without inducing toxicological effects.Signal transducer and activator of transcription 3 inhibitors: a patent review.Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies.Potential use of STAT3 inhibitors in targeted prostate cancer therapy: future prospects.Could signal transducer and activator of transcription 3 be a therapeutic target in obesity-related gastrointestinal malignancy?Novel inhibitors of signal transducer and activator of transcription 3 signaling pathway: an update on the recent patent literature.Novel carbazole inhibits phospho-STAT3 through induction of protein-tyrosine phosphatase PTPN6.Immunologic consequences of signal transducers and activators of transcription 3 activation in human squamous cell carcinoma.Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation Biochemical Properties of a Decoy Oligodeoxynucleotide Inhibitor of STAT3 Transcription Factor.

P2860

Q26822830-C1CA3E6C-7B05-4F8E-B237-BB44326A8B01 Q27021266-D357D34A-C71A-4A29-AFE3-D252DE299D1D Q28538302-7FFAAA1D-8165-42F2-A540-1EAD664F687D Q29547203-60BBA776-BAE6-4892-9CB3-B637FDAA31AC Q30408290-65CD146C-DE78-4100-A9DF-2BEACF9C49CE Q33644206-306A6665-5480-42BD-86FB-797CDFF13121 Q33684732-251898DB-17E1-490D-A5AA-63A70B80CA40 Q33870579-AB74FDCD-BF7F-4144-997C-BE9E8366C312 Q34715455-749C619F-063A-42B9-A05D-2DE453CF8B14 Q35111736-36E7A098-3BAE-4D96-90FB-6B977124AABB Q35925127-C041587C-6FFD-482B-B28D-C4A1D4445457 Q36890491-E6189FC6-E060-43AA-A650-A679BFDCE859 Q37075035-A9D15971-4F9A-4AA1-8DE5-E472631B1291 Q37316179-D9C95A9C-16F1-49B1-BE76-D6E10BC4D267 Q37633227-1D110DF1-915C-4364-85C4-F04273302AA3 Q37813134-8510F5A1-A4E6-4741-8E1D-21676B340B93 Q37910273-F2B674EC-25F2-4011-80A6-1F80B8D92FF1 Q38027835-F5A67185-7E8D-4075-8C05-879CBDE7837E Q38155819-C9D408AC-4D4C-4F5A-AE35-C6B80C1FCD55 Q38179031-E59A66F1-DC9A-4B54-89CF-B0926EBBCD31 Q38979718-F17D0187-64F0-4F88-8FF7-D2C259DE1C77 Q39671902-A16CE0F1-3CC7-4CEF-A7C1-342E7B1B780A Q42425746-C2690EBD-D171-478F-8509-C358FA5AB6F7 Q55642764-025BE0A9-D649-4C83-81BD-F0BAC5F20464

P2860

Lack of toxicity of a STAT3 decoy oligonucleotide.

http://www.wikidata.org/entity/Q36175325

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Lack of toxicity of a STAT3 decoy oligonucleotide.

@ast

Lack of toxicity of a STAT3 decoy oligonucleotide.

@en

type

label

Lack of toxicity of a STAT3 decoy oligonucleotide.

@ast

Lack of toxicity of a STAT3 decoy oligonucleotide.

@en

prefLabel

Lack of toxicity of a STAT3 decoy oligonucleotide.

@ast

Lack of toxicity of a STAT3 decoy oligonucleotide.

@en

P1433

Q36175325-BF132B9A-024B-431D-9ECE-CE5E0FAEDD3A

P1476

Q36175325-F73F47EF-BF5F-4738-969A-E56E14831DEA

P2093

Q36175325-01822CF9-F065-4A5B-BB7B-EBE27E3D7BCC

Q36175325-06DC5F22-7611-4583-A223-D9572C59C3CA

Q36175325-2B57C19B-389F-4D50-A408-69E5EB539250

Q36175325-55433DE6-6F50-448A-AB78-2BA4389B418A

Q36175325-5A55F464-434A-4AEC-A08B-57247B0DD3D6

Q36175325-79E686E3-C96E-4C30-8C2C-F3B2B8CB1900

Q36175325-8FCAEC0F-27D1-4F0A-AF5B-B61D133355BA

Q36175325-C7774030-06A0-4921-A3FB-A4A94D62D6E5

Q36175325-DC4C6B61-199A-4958-B4A9-50401F9698B1

Q36175325-DC726D7C-B7DD-4D7B-B028-9AFE64D697BE

P2860

Q36175325-01FD5B9A-444B-4B6E-90F6-38D73E430EEA

Q36175325-03CA080B-3C27-4406-9F29-C1A01BA18DCB

Q36175325-1676BE72-2EFE-4AB6-B677-BB44E788257A

Q36175325-19FDBF1F-D041-48D5-8461-9AC428500C1D

Q36175325-2E70B1F7-253F-41ED-A439-63C66ECC7E22

Q36175325-2F7BF43A-3A88-411B-87A9-181C2A2DF34F

Q36175325-30816511-AF09-4C39-A363-263BA0BCF82E

Q36175325-312306AD-1BB5-4B16-AE79-BACC758EA51E

Q36175325-316C86FA-00AB-40A8-B9B7-815071101593

Q36175325-347E428D-20D9-43F5-A936-4E4BD417CCB2

P2888

Q36175325-06544BF8-AB8F-4244-8A35-A518DC36835C

P304

Q36175325-0FADA98A-312A-4F17-815B-E8E42E22C451

P31

Q36175325-1BF08AC7-E987-4DA4-8EA3-40E483452014

P356

Q36175325-EA65D1E9-947D-4B0A-A906-65423F2C6D93

P433

Q36175325-4205CC30-29A8-4280-8491-882BAF9A57AD

P478

Q36175325-6DE0A9E0-9FD1-48F1-B256-ACDF3D4D8745

P50

Q36175325-453D7472-F258-4869-8547-5F046766D228

Q36175325-C0C5E448-5544-483D-94BE-C39143D205C4

Q36175325-F58BDEC6-77D8-4161-A206-967CC034A721

P577

Q36175325-C891B4C6-5FE7-43B7-8C71-BAE86A5555BD

P5875

Q36175325-5ECCEEB2-ED03-458C-92F3-E707013F6A27

P698

Q36175325-14F7B36A-F17A-4968-932C-DBB7086A3181

P932

Q36175325-96064F14-7D7E-4477-8106-FF31E54C073E

P356

S00280-008-0823-6

P1433

Cancer Chemotherapy and Pharmacology

P1476

Lack of toxicity of a STAT3 decoy oligonucleotide

@en

P2093

Changyou Li

http://www.w3.org/2001/XMLSchema#string

Christa Zwayer

http://www.w3.org/2001/XMLSchema#string

Daniel E Johnson

http://www.w3.org/2001/XMLSchema#string

James O Peggins

http://www.w3.org/2001/XMLSchema#string

Jerry D Johnson

http://www.w3.org/2001/XMLSchema#string

Joseph E Tomaszewski

http://www.w3.org/2001/XMLSchema#string

Katherine A B Knostman

http://www.w3.org/2001/XMLSchema#string

Michael J Ryan

http://www.w3.org/2001/XMLSchema#string

Michael S Leibowitz

http://www.w3.org/2001/XMLSchema#string

Patricia C Giclas

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality

Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines.

STAT3 as a therapeutic target in head and neck cancer

Stat3 as an oncogene

Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.

Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth

Antisense oligonucleotide-based therapeutics for cancer.

Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo

Targeting Stat3 in cancer therapy.

Rational drug design of G-quartet DNA as anti-cancer agents.

P2888

s00280-008-0823-6

P304

983-995

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-008-0823-6

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer Grandis

P577

2008-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23232537

http://www.w3.org/2001/XMLSchema#string

P698

18766340

http://www.w3.org/2001/XMLSchema#string

P932

3422883

http://www.w3.org/2001/XMLSchema#string